Ultragenyx Pharmaceutical Statistics
Total Valuation
RARE has a market cap or net worth of $2.81 billion. The enterprise value is $3.47 billion.
| Market Cap | 2.81B |
| Enterprise Value | 3.47B |
Important Dates
The next estimated earnings date is Monday, August 3, 2026, after market close.
| Earnings Date | Aug 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RARE has 98.19 million shares outstanding. The number of shares has increased by 6.60% in one year.
| Current Share Class | 98.19M |
| Shares Outstanding | 98.19M |
| Shares Change (YoY) | +6.60% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 3.71% |
| Owned by Institutions (%) | 99.88% |
| Float | 94.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.18 |
| Forward PS | 3.49 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.02
| Current Ratio | 2.02 |
| Quick Ratio | 1.65 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -25.45% |
| Return on Invested Capital (ROIC) | -32.99% |
| Return on Capital Employed (ROCE) | -54.69% |
| Weighted Average Cost of Capital (WACC) | 5.52% |
| Revenue Per Employee | $488,694 |
| Profits Per Employee | -$444,201 |
| Employee Count | 1,371 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 16.98 |
Taxes
In the past 12 months, RARE has paid $4.00 million in taxes.
| Income Tax | 4.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.81% in the last 52 weeks. The beta is 0.31, so RARE's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +7.81% |
| 50-Day Moving Average | 27.26 |
| 200-Day Moving Average | 27.20 |
| Relative Strength Index (RSI) | 42.81 |
| Average Volume (20 Days) | 2,856,635 |
Short Selling Information
The latest short interest is 16.22 million, so 16.52% of the outstanding shares have been sold short.
| Short Interest | 16.22M |
| Short Previous Month | 14.31M |
| Short % of Shares Out | 16.52% |
| Short % of Float | 17.16% |
| Short Ratio (days to cover) | 5.36 |
Income Statement
In the last 12 months, RARE had revenue of $670.00 million and -$609.00 million in losses. Loss per share was -$6.11.
| Revenue | 670.00M |
| Gross Profit | -188.00M |
| Operating Income | -531.00M |
| Pretax Income | -605.00M |
| Net Income | -609.00M |
| EBITDA | -497.00M |
| EBIT | -531.00M |
| Loss Per Share | -$6.11 |
Balance Sheet
The company has $413.00 million in cash and $1.20 billion in debt, with a net cash position of -$666.00 million or -$6.78 per share.
| Cash & Cash Equivalents | 413.00M |
| Total Debt | 1.20B |
| Net Cash | -666.00M |
| Net Cash Per Share | -$6.78 |
| Equity (Book Value) | -229.00M |
| Book Value Per Share | -2.41 |
| Working Capital | 332.00M |
Cash Flow
In the last 12 months, operating cash flow was -$497.00 million and capital expenditures -$6.00 million, giving a free cash flow of -$503.00 million.
| Operating Cash Flow | -497.00M |
| Capital Expenditures | -6.00M |
| Depreciation & Amortization | 34.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -503.00M |
| FCF Per Share | -$5.12 |
Margins
Gross margin is -28.06%, with operating and profit margins of -79.25% and -90.90%.
| Gross Margin | -28.06% |
| Operating Margin | -79.25% |
| Pretax Margin | -90.30% |
| Profit Margin | -90.90% |
| EBITDA Margin | -74.18% |
| EBIT Margin | -79.25% |
| FCF Margin | n/a |
Dividends & Yields
RARE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.60% |
| Shareholder Yield | -6.60% |
| Earnings Yield | -21.74% |
| FCF Yield | -17.96% |
Analyst Forecast
The average price target for RARE is $52.53, which is 83.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $52.53 |
| Price Target Difference | 83.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | 22.02% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RARE has an Altman Z-Score of -4.48 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.48 |
| Piotroski F-Score | 2 |